08048035968
Premium Indian Pharma Source for Novomix 30 Penfill | Canada Export Network | Phoenix Exim

1. General Information

NovoMix 30 Penfill is a premixed insulin formulation containing insulin aspart in two forms: a rapid-acting component and a longer/intermediate-acting component. It is used to help control elevated blood glucose in people with diabetes. It is indicated for adults, adolescents, and children aged 10 years and above.

NovoMix 30 is generally administered around mealtimes and should be used only according to a healthcare professional's prescription and instructions.

2. Product Information

  • Brand: NovoMix 30 Penfill
  • Active ingredient: Insulin aspart
  • Composition: 30% soluble insulin aspart + 70% insulin aspart crystallised with protamine
  • Strength: 100 units/mL
  • Cartridge: 3 mL
  • Total insulin per cartridge: 300 units
  • Dosage form: Suspension for injection
  • Route: Subcutaneous injection
  • Device: Reusable compatible insulin pen
  • Therapeutic category: Antidiabetic/insulin
  • Manufacturer: Novo Nordisk

The suspension should appear uniformly white, cloudy and aqueous after proper resuspension. Do not use it if it remains unusually clear, contains clumps, or has solid particles adhering to the cartridge.

3. Uses of NovoMix 30 Penfill

NovoMix 30 is prescribed to help control high blood glucose associated with diabetes mellitus. It may be used in type 1 diabetes and type 2 diabetes according to the individual's treatment plan.

For some people with type 2 diabetes, it may be prescribed alone or together with other diabetes medicines.

4. Benefits of This Medicine

When prescribed appropriately, NovoMix 30 can:

  • Help lower elevated blood glucose.
  • Provide both rapid and intermediate-duration insulin activity.
  • Help manage blood glucose around meals.
  • Support improved overall glycaemic control when combined with an appropriate diet, physical activity and diabetes-management plan.
  • Provide a premixed insulin option for patients whose healthcare professional considers this formulation appropriate.

NovoMix 30 begins lowering blood glucose approximately 10–20 minutes after injection, with maximum effect generally occurring between 1 and 4 hours; the duration can be up to approximately 24 hours, although it varies between individuals.

5. Side Effects of NovoMix 30

Like other insulin medicines, NovoMix 30 can cause side effects. The most important and most frequently reported adverse effect is hypoglycaemia (low blood sugar).

Other possible reactions include:

  • Injection-site reactions
  • Skin thickening or thinning at injection sites
  • Swelling (oedema)
  • Temporary vision changes
  • Skin rash or hives
  • Allergic reactions
  • Rarely, severe allergic reactions

Severe hypoglycaemia can cause confusion, seizures, loss of consciousness and may become life-threatening if untreated.

6. Common Side Effects

The most important common/very common side effect is:

Hypoglycaemia (low blood sugar) — symptoms can include sweating, pale or cool skin, hunger, headache, trembling, weakness, dizziness, anxiety, confusion, drowsiness, difficulty concentrating, nausea and changes in vision.

Injection-site reactions and changes in fatty tissue under the skin can also occur. Rotating injection sites can help reduce these problems.

If severe low blood sugar causes unconsciousness, emergency medical assistance is required.

7. How to Use NovoMix 30 Penfill

NovoMix 30 should be used exactly according to the dose and schedule prescribed by your doctor. Do not independently change your insulin dose.

General administration principles include:

  1. Check that you have the correct insulin.
  2. Resuspend the cartridge according to the manufacturer's instructions before injection.
  3. Use NovoMix 30 Penfill with a compatible reusable insulin pen.
  4. Use a new needle for every injection.
  5. Inject subcutaneously rather than into a vein or muscle.
  6. Rotate injection sites within the recommended areas.
  7. NovoMix 30 is generally administered immediately before a meal; a meal should normally begin within about 10 minutes after injection. It may sometimes be administered shortly after a meal when directed by a healthcare professional.

Do not use NovoMix 30 in an insulin infusion pump or administer it intravenously.

8. How NovoMix 30 Works

NovoMix 30 combines two forms of insulin aspart:

  • 30% soluble insulin aspart provides rapid insulin activity.
  • 70% protamine-crystallised insulin aspart provides a longer/intermediate insulin effect.

Together, these components help replace or supplement insulin and promote the movement of glucose from the bloodstream into tissues, thereby lowering blood glucose levels.

9. Safety Advice

  • Use NovoMix 30 only when prescribed by a qualified healthcare professional.
  • Monitor blood glucose as advised.
  • Never change your insulin dose without medical guidance.
  • Do not skip or delay meals after taking NovoMix 30 without appropriate medical advice because this can increase the risk of hypoglycaemia.
  • Always check the insulin label before use.
  • Do not use a cartridge that is damaged, frozen, improperly stored or visually abnormal.
  • Never share your Penfill cartridge, insulin pen or needles with another person.
  • Rotate injection sites to reduce lumps or changes in fatty tissue.
  • Take particular care when driving or operating machinery because hypoglycaemia can impair concentration and reaction time.
  • Tell your doctor about other medicines you take because some medicines can affect insulin requirements and blood glucose.
  • If you are travelling across time zones, discuss insulin and meal timing with your healthcare professional beforehand.
  • Seek urgent medical help for severe hypoglycaemia, loss of consciousness, breathing difficulty, facial/throat swelling or other signs of a serious allergic reaction.

Storage: Follow the product-specific storage instructions. Once in use or carried as a spare, the Penfill cartridge should generally be kept below 30°C and discarded after the specified period rather than being kept refrigerated indefinitely.

10. FAQs

Q1. What is NovoMix 30 Penfill used for?
It is an insulin medicine used to control blood glucose in people with diabetes.

Q2. What is the strength of NovoMix 30 Penfill?
It contains 100 units/mL. A 3 mL cartridge contains 300 units of insulin aspart.

Q3. What does NovoMix 30 contain?
It contains 30% soluble insulin aspart and 70% insulin aspart crystallised with protamine.

Q4. When is NovoMix 30 normally taken?
It is generally injected immediately before a meal, with food normally started within about 10 minutes.

Q5. Can I change my NovoMix 30 dose myself?
No. Insulin doses should be adjusted according to your healthcare professional's instructions and blood-glucose monitoring.

Q6. What happens if I take too much NovoMix 30?
Too much insulin can cause hypoglycaemia. Severe hypoglycaemia can be dangerous and requires prompt treatment and, in severe cases, emergency medical attention.

Q7. Can NovoMix 30 be injected into a vein?
No. NovoMix 30 Penfill is intended for subcutaneous injection and should not be administered intravenously.

Q8. Can NovoMix 30 Penfill be shared?
No. Penfill cartridges, insulin pens and needles must not be shared between patients.

Q9. Is NovoMix 30 suitable for children?
It is indicated for children aged 10 years and above, adolescents and adults, under appropriate medical supervision.

Q10. Is NovoMix 30 a prescription medicine?
Yes. It should be used under the supervision of an appropriate healthcare professional.

11. Substitute for NovoMix 30

There is no single universally suitable substitute because insulin selection depends on the patient's diabetes type, glucose profile, meal pattern, current insulin regimen and other medical factors.

Possible alternatives may include other premixed insulin preparations or different insulin regimens, such as basal-bolus therapy, but they are not automatically dose-equivalent to NovoMix 30.

A doctor should determine whether another insulin is appropriate and establish the correct dose. The official product information specifically advises that changes from one insulin type or brand to another should be made cautiously and under medical supervision because dose adjustment may be required.

12. SEO Keywords

For Phoenix Exim, Nagpur, India, relevant B2B/export-focused keywords can include:

  • NovoMix 30 Penfill exporter from India
  • NovoMix 30 Penfill supplier India
  • NovoMix 30 Penfill pharmaceutical exporter
  • NovoMix 30 Penfill wholesale supplier
  • NovoMix 30 Penfill bulk supplier India
  • NovoMix 30 Penfill medicine exporter Nagpur
  • NovoMix 30 insulin Penfill supplier
  • Insulin aspart exporter from India
  • NovoMix 30 Penfill international supplier
  • NovoMix 30 Penfill global pharmaceutical supplier
  • NovoMix 30 Penfill export from India
  • NovoMix 30 Penfill supplier USA
  • NovoMix 30 Penfill supplier UK
  • NovoMix 30 Penfill supplier Australia
  • NovoMix 30 Penfill supplier Canada
  • NovoMix 30 Penfill supplier Singapore
  • NovoMix 30 Penfill supplier South Korea
  • NovoMix 30 Penfill supplier UAE
  • Diabetes medicine exporter from India
  • Insulin medicine exporter India
  • Premium pharmaceutical exporter Nagpur
  • Trusted Indian pharma exporter
  • Indian pharmaceutical wholesale supplier
  • International diabetes medicine supplier
  • NovoMix 30 100 units/ml Penfill
  • NovoMix 30 3ml cartridge supplier
  • Insulin aspart 100 units/ml exporter
  • Premixed insulin supplier India
  • Diabetes care medicine exporter India
  • Phoenix Exim pharmaceutical exporter
Sep 8th, 2026 2:19 PM

Keywords